|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables显示文摘 | Eslam M Ampuero J Jover M | 2013 | Ann Hepatol2013，12，4： | 1 |
| 2 | Insulin resistance and hepatitis c:an evolving story 显示文摘 | ESLAM M KHATTAB M A HARRISON S A | 2011 | Gut2011，60，8： | 1 |
| 3 | IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection 显示文摘 | Eslam M Leung R Romero-Gomez M | 2014 | J Hepatol2014，61，2： | 1 |
| 4 | An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease显示文摘Background:With the rising global prevalence of fatty liver disease related to metabolic dysfunction,the association of this common liver condition with chronic kidney disease(CKD)has become increasingly evident.In 2020,the more inclusive term metabolic dysfunction-associated fatty liver disease(MAFLD)was proposed to replace the term non-alcoholic fatty liver disease(NAFLD).The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD.However,to date,there is no appropriate guidance on CKD in individuals with MAFLD.Furthermore,there has been little attention paid to the link between MAFLD and CKD in the Nephrology community.Methods and Results:Using a Delphi-based approach,a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD.Conclusions:This Delphi-based consensus statement provided guidance on the epidemiology,mechanisms,management and treatment of MAFLD and CKD,as well as the relationship between the severity of MAFLD and risk of CKD,which establish a framework for the early prevention and management of these two common and interconnected diseases. | Dan-Qin Sun Giovanni Targher Christopher D.Byrne David C.Wheeler Vincent Wai-Sun Wong Jian-Gao Fan Herbert Tilg Wei-Jie Yuan Christoph Wanner Xin Gao Michelle T.Long Mehmet Kanbay Mindie H.Nguyen Sankar D.Navaneethan Yusuf Yilmaz Yuli Huang Rino A.Gani Pierluigi Marzuillo Jérôme Boursier Huijie Zhang Chan-Young Jung Jin Chai Luca Valenti George Papatheodoridis Giovanni Musso Yu-Jun Wong Mohamed El-Kassas Nahum Méndez-Sánchez Silvia Sookoian Michael Pavlides Ajay Duseja Adriaan G.Holleboom Junping Shi Wah-Kheong Chan Yasser Fouad Junwei Yang Sombat Treeprasertsuk Helena Cortez-Pinto Masahide Hamaguchi Manuel Romero-Gomez Mamun Al Mahtab Ponsiano Ocama Atsushi Nakajima Chunsun Dai Mohammed Eslam Lai Wei Jacob George Ming-Hua Zheng | 2023 | Hepatobiliary Surgery and Nutrition2023，12，3： | 1 |
| 5 | Sonographic gallbladder wall thickness measurement and the prediction of esophageal varices among cirrhotics显示文摘Acute variceal bleeding in patients with liver cirrhosis and portal hypertension(PHT) is the most serious emergency complication among those patients and could have catastrophic outcomes if not timely managed. Early screening by esophago-gastro-duodenoscopy(EGD) for the presence of esophageal varices(EVs) is currently recommended by the practice guidelines for all cirrhotic patients. Meanwhile, EGD is not readily accepted or preferred by many patients. The literature is rich in studies to investigate and validate non-invasive markers of EVs prediction aiming at reducing the unneeded endoscopic procedures. Gallbladder(GB) wall thickness(GBWT) measurement has been found promising in many published research articles. We aim to highlight the validity of sonographic GBWT measurement in the prediction of EVs based on the available evidence. We searched databases including Cochrane library, Pub Med, Web of Science and many others for relevant articles. GBWT is associated with the presence of EVs in cirrhotic patients with PHT of different etiologies. The cut-off of GBWT that can predict the presence of EVs varied in the literature and ranges from 3.1 mm to 4.35 mm with variable sensitivities of 46%-90.9% and lower cutoffs in viral cirrhosis compared to non-viral, however GBWT > 4 mm in many studies is associated with acceptable sensitivity up to 90%. Furthermore, a relation was also noticed with the degree of varices and portal hypertensive gastropathy.Among cirrhotics, GBWT > 3.5 mm predicts the presence of advanced(grade Ⅲ-Ⅳ) EVs with a sensitivity of 45%, the sensitivity increased to 92% when a cut-off ≥ 3.95 mm was used in another cohort. Analysis of these results should carefully be revised in the context of ascites, hypoalbuminemia and other intrinsic GB diseases among cirrhotic patients. The sensitivity for prediction of EVs improved upon combining GBWT measurement with other non-invasive predictors, e.g., platelets/GBWT. | Mohamed H Emara Mariam Zaghloul Ibrahim F Amer Aya M Mahros Mohammed Hussien Ahmed Mahmoud A Elkerdawy Eslam Elshenawy Abdelrahman M Ahmed Rasheda Tarik I Zaher Mona Talaat Haseeb Emad Hassan Emara Hassan Elbatae | 2023 | World Journal of Hepatology2023，15，2： | 1 |
| 6 | Meta-analysis: insulin resistance and sustained virological response in hepatitis C 显示文摘 | Eslam M Aparcero R Kawaguchi T | 2011 | Aliment Pharmacol Ther2011，34，3： | 1 |
| 7 | Association of serumadipocytokines with insulin resistance and liver injury in patientswith chronic hepatitis C genotype 4 显示文摘 | KHATTAB MA ESLAM M ALY MM | 2012 | J Clin Gastroenterol2012，46，10： | 1 |
| 8 | The significance of carbon nan- otubes on styrene butadiene rubber (SBL) and SBL modified mortar显示文摘 | Eslam M Soliman U F Kandil M M | 2012 | Materials and Structures2012，45，6： | 1 |
| 9 | Association between meta- bolic abnormalities and hepatitis C - related hepatocellular carcino- ma显示文摘 | Khattab MA Eslam M Mousa YI | 2012 | Ann Hepato12012，11，4： | 1 |
| 10 | Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment显示文摘 | Romero - Gomez M Eslam M Ruiz A | 2011 | Liver Int2011，31，4： | 1 |
| 11 | Face recognition in low resolution thermal images显示文摘 | Eslam M Riad H Asem A | 2013 | Computer Vision and Image Understanding2013，117，： | 1 |
| 12 | Expression of Shigella flexneri ipaB Gene in Tobacco 显示文摘 | Ohadi M Rasouli R Darzi - Eslam E | 2013 | Avicenna J Med Biotechnol2013，5，2： | 1 |
| 13 | Ovarian thecal metaplasia of the adrenal gland in association with Beckwith-Wiedemann syndrome显示文摘Beckwith-Wiedemann syndrome(BWS) is an overgrowth syndrome associated with increased risk to develop malignancies including adrenocortical carcinoma. Ovarian thecal metaplasia of the adrenal gland is a rare tumorlike mesenchymal lesion in BWS patients that lacks detailed radiological description. We report a 17-yearold female patient with BWS, associated with bilateral Wilms tumor, hepatic hemangiomatosis, pancreatic neuroendocrine tumor, and a phyllodes tumor of the right breast. Surveillance abdominal ultrasound identified a right adrenal mass that was further characterized by computed tomography and magnetic resonance imaging. Radiologically, this mass displayed features that overlap with adrenocortical carcinoma and pheochromocytoma but after pathological examination this proved to be an ovarian thecal metaplasia of the adrenal gland. Adrenal masses in BWS should raise the suspicion for adrenocortical carcinoma though other adrenal tumors including ovarian thecal metaplasia can be seen in these patients. | Eslam Y Wassal Mouhammed Amir Habra Rafael Vicens Priya Rao Khaled M Elsayes | 2014 | World Journal of Radiology2014，6，12： | 0 |
| 14 | 病毒性和非病毒性慢性肝脏疾病中干扰素λRS12979860基因型与肝纤维化的相关性研究显示文摘【据《Nat Commun》2015年5月报道】题:病毒性和非病毒性慢性肝脏疾病中干扰素λRS12979860基因型与肝纤维化的相关性研究(作者Eslam M等)组织纤维化是促使约45%人群死亡的关键病理学过程。组织纤维化很可能受宿主遗传结构的影响。来自悉尼大学的Eslam M等以肝脏疾病为模型进行研究,证明了IFNL4内含子区域的RS12979860多态性位点是一个强的肝纤维化预测因子,并且与病原学无关。该项研究共纳入4172位患者,包括3129位慢性丙型肝炎、555位慢性乙型肝炎患者和488位非酒精性脂肪性肝病患者;结果显示RS12979860 CC型患者有更严重的炎症和纤维化水平。 | 吴瑞红 温晓玉 Eslam M | 2015 | 临床肝胆病杂志2015，31，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员